CD68/macrosialin: not just a histochemical marker

Dimitry A Chistiakov1, Murry C Killingsworth2,3,4, Veronika A Myasoedova5,6

  • 1Department of Molecular Genetic Diagnostics and Cell Biology, Division of Laboratory Medicine, Institute of Pediatrics, Research Center for Children's Health, Moscow, Russia.

Insights

CD68 is a key marker for macrophages, valuable in diagnosing cancer and inflammation. Its role in immune responses and conditions like atherosclerosis requires further investigation.

Area of Science:

  • Immunology
  • Cell Biology
  • Pathology

Background:

  • CD68 is a heavily glycosylated glycoprotein predominantly expressed in macrophages and mononuclear phagocytes.
  • It serves as a crucial cytochemical marker for identifying these cells in histochemical and immunohistopathological analyses of various tissues.
  • CD68 expression is also observed in lymphoid cells, non-hematopoietic cells, and tumor cells, with levels influenced by transcriptional and epigenetic factors.

Purpose of the Study:

  • To explore the multifaceted roles and functions of CD68 beyond its established use as a macrophage marker.
  • To investigate the potential of CD68 as a prognostic marker in cancer patients.
  • To elucidate the structural and functional characteristics of CD68, including its ligand-binding capabilities and cellular localization.

Main Methods:

  • Immunohistochemistry and cytochemical analysis to detect CD68 expression in various tissue types.
  • Analysis of gene expression patterns and regulatory mechanisms controlling CD68.
  • Structural comparison of human CD68 with its mouse ortholog (macrosialin) and other LAMP proteins.
  • Investigation of CD68's ligand-binding properties and cellular trafficking.

Main Results:

  • CD68 expression levels vary across different cell types, with low expression in lymphoid, non-hematopoietic, and tumor cells.
  • CD68 demonstrates prognostic value in cancer patients, particularly when combined with other tumor-associated macrophage markers.
  • CD68 binds to ligands such as oxLDL, phosphatidylserine, and apoptotic cells, and acts as a receptor for malaria sporozoites.
  • CD68's role in immune responses is limited, but it may be involved in antigen processing and is crucial for osteoclast function.
  • The role of CD68 in atherosclerosis remains controversial.

Conclusions:

  • CD68 is a versatile marker with significant implications in pathology, particularly in cancer prognosis.
  • Its structural features, including a mucin-like domain, facilitate ligand binding, though its function as a scavenger receptor needs confirmation.
  • CD68 plays a critical role in osteoclast function, impacting bone resorption.
  • Further research is needed to clarify CD68's precise involvement in immune responses and complex diseases like atherosclerosis.

Related Concept Videos